A novel exosome-derived prognostic signature and risk stratification for breast cancer based on multi-omics and systematic biological heterogeneity

Tumor heterogeneity remains a major challenge for disease subtyping, risk stratification, and accurate clinical management. Exosome-based liquid biopsy can effectively overcome the limitations of tissue biopsy, achieving minimal invasion, multi-point dynamic monitoring, and good prognosis assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Fei, Ma, Haodong, Hao, Youjin, Tian, Luyao, Li, Yinghong, Li, Bo, Chen, Juan, Tang, Ying, Li, Jing, Deng, Lili, Xie, Guoming, Liu, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232662/
https://www.ncbi.nlm.nih.gov/pubmed/37273850
http://dx.doi.org/10.1016/j.csbj.2023.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232662/
https://www.ncbi.nlm.nih.gov/pubmed/37273850
http://dx.doi.org/10.1016/j.csbj.2023.05.013

Ejemplares similares